Biotechnology
Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland China
SHANGHAI, May 14, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced that NEFECON®, a delayed rel...
2024-05-14 21:41
612
HealthTech Bioactives Partners with Abolis for Sustainable Production of High-Value Polyphenols
PARIS, May 14, 2024 /PRNewswire/ -- HealthTech Bioactives (HTBA) has chosen Abolis as their partner to develop strains to produce valuable polyphenols, addressing supply chain challenges and driving innovation in the industry. Founded in 2019, after 40 years' experience under different ownership,...
2024-05-14 20:00
553
HUB Organoids B.V. Awarded Frost & Sullivan's 2024 Technology Innovation Leadership Award for Transforming Drug Development with Highly Advanced Organoid Technology
HUB Organoids Holdings B.V. revolutionizes pre-clinical and clinical drug development through its cutting-edge organoid technology, enhancing its accuracy and efficiency. SAN ANTONIO, May 14, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the organoids landscape and, based on its find...
2024-05-14 20:00
618
Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions
SINGAPORE, May 14, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a$15 million Series A funding round led by Seventure Partners ofFrance and Xora Innovation of Singapore. This significant investment underscores the growing re...
2024-05-14 11:24
1271
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies
DURHAM, N.C. and BEIJING, May 14, 2024 /PRNewswire/ -- Brii Biosciences Limited
2024-05-14 07:27
1027
BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
SHENZHEN, China, May 13, 2024 /PRNewswire/ -- On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated inHarbin, Heilongjiang province, China, marking a significant advance in the province's efforts to address public healt...
2024-05-13 13:34
1284
SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting Highlighting Superior Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad Range of HPV-associated Cancers
SINGAPORE, May 13, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced first preclinical data of its novel human papillomavirus (HPV)-specific T cell receptor-...
2024-05-13 10:00
2285
RemeGen Celebrates World Lupus Day 2024 with Increased Lupus Visibility through Vital Knowledge Sharing
The biotech company continues to offer hope to systemic lupus erythematosus (
SLE) patients globally by sharing the latest developments of its proprietary
novel fusion protein drug Telitacicept
YANTAI, China, May 10, 2024 /PRNewswire/ -- RemeGen Co. Ltd.
2024-05-10 16:26
1779
Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology
First and only contact force pulsed field ablation (PFA) system designed to transform treatment for millions with life-threatening ventricular arrhythmias. Preliminary data of VCAS study will be presented at HRS 2024 in Boston, Mass. CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field M...
2024-05-09 20:03
1636
Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
Publication in Human Vaccines and Immunotherapeutics highlights progress in understanding tumour biology and vaccine technologies since the pandemic OXFORD, England, May 9, 2024 /PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in pr...
2024-05-09 15:30
1719
Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints
SAN FRANCISCO and SUZHOU, China, May 9, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, o...
2024-05-09 08:00
1553
Körber Pharma and Siemens Take the Lead in ABI Research's MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive Ranking
LONDON, May 8, 2024 /PRNewswire/ -- The new Competitive Assessment by global technology intelligence firmABI Research provides an in-depth and unbiased examination of the solutions offered by 13 manufacturing execution system (MES) software suppliers targeting pharmaceutical, biotech, and cell & ...
2024-05-08 20:30
1155
NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBio
* Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearlyUS$400 million funding in total alongside significant business milestones * NSG BioLabs' partnerships with EnterpriseSG and ...
2024-05-08 10:00
1741
YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer
GAITHERSBURG, Md., May 8, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disease...
2024-05-08 04:20
1364
Seragon Completes Pre-Clinical Study of Aging Intervention Candidate SRN-901
IRVINE, Calif., May 7, 2024 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the completion of a pre-clinical study on its novel anti-aging candidate, SRN-901. This pivotal study, conducted in mice, was undertaken to evaluate the impact of SRN-901 on aging as well as various health marke...
2024-05-07 22:10
1296
Imaging Endpoints Unveils New Initiative with Revolution Endpoints™, an Investment Subsidiary to Accelerate Innovation and Growth
SCOTTSDALE, Ariz., May 7, 2024 /PRNewswire/ -- Imaging Endpoints (IE), a global leader in Imaging CRO technologies and services, has announced the formation of a new subsidiary, Revolution Endpoints, focused on leveraging the Company's strong leadership and financial position to acquire synergist...
2024-05-07 21:00
1180
Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for Ecnoglutide Injection (XW003) in South Korea
HANGZHOU, China and SEOUL, South Korea, May 7, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation, a South Korean commercial stage pharmaceutical company (KOSDAQ: 195940),...
2024-05-07 15:00
1069
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis LONDON, May 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intellig...
2024-05-07 15:00
977
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343（Anti-Claudin18.2 ADC）as Monotherapy for Advanced Gastric Cancer
SAN FRANCISCO and SUZHOU, China, May 7, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...
2024-05-07 08:12
1309
HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications
JAVENÉ, France, May 6, 2024 /PRNewswire/ -- HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American company Modern Meadow (Nutley, NJ). Notably, this acquisitio...
2024-05-07 07:00
1116
Week's Top Stories
Most Reposted
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 321 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 312 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 299 media titles]
2024-05-08 16:44
Thousands set to gather in Singapore for Rotary's international convention, the Garden City's largest association event post-pandemic
[Picked up by 289 media titles]
2024-05-09 11:00
i2Cool Attracts Close to HKD100 Million in Series A Financing to Propel the Development of Green and Energy-Efficient Radiant Cooling Solutions
[Picked up by 283 media titles]
2024-05-09 10:50
Most Read
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
2024-05-08 14:37
12457
IN2MF in Kuala Lumpur Presented by Bank Indonesia
2024-05-08 16:44
12077
